Israeli Ministry of Health approves Elite's generic Adderall; first shipment months away

ELITE PHARMACEUTICALS INC /NV/

Israeli Ministry of Health approved Elite's generic Adderall (mixed amphetamine salts) in 10mg, 20mg, 30mg tablets on Oct 7, 2024.
Elite will supply to exclusive distributor Dexcel Pharma for the Israeli market; Dexcel handles sales/marketing at its expense.
Product jointly owned by Elite and Mikah Pharma; first shipment depends on licensee orders, DEA quotas, and manufacturing.
Under license agreement, Dexcel pays transfer price and shares profits under certain conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.